TY - JOUR
T1 - Prevalence of malnutrition in patients at first medical oncology visit
AU - Muscaritoli, Maurizio
AU - Lucia, Simone
AU - Farcomeni, Alessio
AU - Lorusso, Vito
AU - Saracino, Valeria
AU - Barone, Carlo
AU - Plastino, Francesca
AU - Gori, Stefania
AU - Magarotto, Roberto
AU - Carteni, Giacomo
AU - Chiurazzi, Bruno
AU - Pavese, Ida
AU - Marchetti, Luca
AU - Zagonel, Vittorina
AU - Bergo, Eleonora
AU - Tonini, Giuseppe
AU - Imperatori, Marco
AU - Iacono, Carmelo
AU - Maiorana, Luigi
AU - Pinto, Carmine
AU - Rubino, Daniela
AU - Cavanna, Luigi
AU - Di Cicilia, Roberto
AU - Gamucci, Teresa
AU - Quadrini, Silvia
AU - Palazzo, Salvatore
AU - Minardi, Stefano
AU - Merlano, Marco
AU - Colucci, Giuseppe
AU - Marchetti, Paolo
AU - Group, PreMiO Study
PY - 2017/10/3
Y1 - 2017/10/3
N2 - Background: In cancer patients, malnutrition is associated with treatment toxicity, complications, reduced physical functioning, and decreased survival. The Prevalence of Malnutrition in Oncology (PreMiO) study identified malnutrition or its risk among cancer patients making their first medical oncology visit. Innovatively, oncologists, not nutritionists, evaluated the nutritional status of the patients in this study.Methods: PreMiO was a prospective, observational study conducted at 22 medical oncology centers across Italy. For inclusion, adult patients (>18 years) had a solid tumor diagnosis, were treatment-naive, and had a life expectancy >3 months. Malnutrition was identified by the Mini Nutritional Assessment (MNA), appetite status with a visual analog scale (VAS), and appetite loss with a modified version of Anorexia-Cachexia Subscale (AC/S-12) of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT).Findings: Of patients enrolled (N=1,952), 51% had nutritional impairment; 9% were overtly malnourished, and 43% were at risk for malnutrition. Severity of malnutrition was positively correlated with the stage of cancer. Over 40% of patients were experiencing anorexia, as reported in the VAS and FAACT questionnaire. During the prior six months, 64% of patients lost weight (1-10 kg).Interpretation: Malnutrition, anorexia, and weight loss are common in cancer patients, even at their first visit to a medical oncology center.
AB - Background: In cancer patients, malnutrition is associated with treatment toxicity, complications, reduced physical functioning, and decreased survival. The Prevalence of Malnutrition in Oncology (PreMiO) study identified malnutrition or its risk among cancer patients making their first medical oncology visit. Innovatively, oncologists, not nutritionists, evaluated the nutritional status of the patients in this study.Methods: PreMiO was a prospective, observational study conducted at 22 medical oncology centers across Italy. For inclusion, adult patients (>18 years) had a solid tumor diagnosis, were treatment-naive, and had a life expectancy >3 months. Malnutrition was identified by the Mini Nutritional Assessment (MNA), appetite status with a visual analog scale (VAS), and appetite loss with a modified version of Anorexia-Cachexia Subscale (AC/S-12) of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT).Findings: Of patients enrolled (N=1,952), 51% had nutritional impairment; 9% were overtly malnourished, and 43% were at risk for malnutrition. Severity of malnutrition was positively correlated with the stage of cancer. Over 40% of patients were experiencing anorexia, as reported in the VAS and FAACT questionnaire. During the prior six months, 64% of patients lost weight (1-10 kg).Interpretation: Malnutrition, anorexia, and weight loss are common in cancer patients, even at their first visit to a medical oncology center.
KW - Journal Article
M3 - Article
VL - 8
SP - 79884
EP - 79896
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 45
ER -